Cochrane · systematic review · CD008616
Zolmitriptan for acute migraine attacks in adults
Bird, S, Derry, S, Moore, RA · Cochrane Database of Systematic Reviews · 2014 · Cochrane Library
Pain, Palliative and Supportive CareAMSTAR 2: not assessed
SoF tableOnly the outcomes this review put in its Summary of Findings table are listed (the Cochrane Handbook caps them at about seven per comparison). Its other analyses are not shown here.
Questions
7
current version
GRADE rated
7
No studies
0
Included studies
NR
No studies 0 · 0%Ungraded 0 · 0%Very low 0 · 0%Low 0 · 0%Moderate 2 · 28.6%High 5 · 71.4%
Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.
Questions and results
Comparison
Population: adults with migraine headache ‐ moderate or severe pain
| Outcome | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Pain‐free response at 2 h | no estimate extracted | NR | High |
Headache relief at 2 h | no estimate extracted | NR | High |
Headache relief at 1 h | no estimate extracted | NR | High |
Sustained pain‐free during the 24 h post dose | no estimate extracted | NR | Moderate |
Sustained headache relief during the 24 h post dose | no estimate extracted | NR | High |
At least one AE | no estimate extracted | NR | High |
Serious AE* | no estimate extracted | NR | Moderate |